News | Analytics Software | February 01, 2017

Almost Three-quarters of Healthcare Companies Will Invest in Big Data by 2021

New business intelligence cites technological advancements and declining costs as major drivers, stresses importance of adoption

big data, GBI Research, 2021, healthcare companies, Arshad Ahad

Big data showing a CDC versus Twitter study of cardiovascular disease predictions from an American College of Cardiology (ACC) slide.


February 1, 2017 — As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73 percent of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.

The company’s latest report states that there are a number of factors promoting the use of big data in healthcare. Arshad Ahad, analyst for GBI Research, explained: “Advances in technology have led to an explosion in healthcare-related data generation. This data represents an invaluable resource, which can bring many commercial benefits to organizations if properly utilized and acted upon, although the fundamental properties of big data – its volume, velocity and variability – make this a challenging prospect”.

The advancement in technologies and a commensurate decline in costs of genome sequencing, for example, have increased the rate of biological data generation at an exponential rate, evidenced by data from the National Human Genome Research Institute. As costs fall further, it may be feasible in the near future to store genomic data for large subsets of patients, or even every patient. This would represent a huge technical challenge, but the analytical benefits it could provide are enormous.

The commercial benefits big data can provide are incentivizing pharmaceutical and healthcare companies to embrace the technology. Mining data in conjunction with predictive modeling, for example, could be used to identify new drug candidates with a greater likelihood of success.

Big data could also be used to overhaul clinical trial processes, making them more powerful, shorter and less expensive. Other uses of this data include using the technology to detect waste and inappropriate use of resources, aid in the development of personalized therapies, implement value-based healthcare and collect real-world evidence.

Ahad continued: “Big data is no longer an abstract concept that could provide benefits in the future. It exists now and is already providing competitive advantages for a variety of organizations. As such, companies which ignore its potential risk falling behind their peers in our increasingly data-intensive world.”

For more information: www.gbiresearch.com

Related Content

News | Analytics Software
February 15, 2022 – Cleerly, the company creating a new standard of care for heart disease, announced its latest product ...
Home February 15, 2022
Home
Feature | Analytics Software

Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is ...

Home October 27, 2021
Home
Webinar | Analytics Software

The current landscape of healthcare places increased importance on understanding of operational data and efficient ...

Home September 16, 2020
Home
Technology | Analytics Software

May 17, 2019 — Digital healthcare company Murj announced the availability of the Murj Analytics software-as-a-service ...

Home May 17, 2019
Home
Technology | Analytics Software

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s Cartonet to ...

Home May 16, 2019
Home
News | Analytics Software

February 28, 2018 — Lumedx Corp. will show off the latest in advanced analytics and software solutions at the upcoming ...

Home February 28, 2018
Home
Technology | Analytics Software

December 11, 2017 — Siemens Healthineers has launched teamplay Cardio, a new cardiology analytics dashboard application ...

Home December 11, 2017
Home
Sponsored Content | Videos | Analytics Software

The shift to value-based payment models requires focused attention on quality and cost. Lumedx’s Cardiovascular ...

Home April 13, 2017
Home
Videos | Analytics Software

Pam Rush, RN, MS, clinical program director, cardiovascular service line, and Craig Strauss, M.D., MPH, medical director ...

Home March 15, 2017
Home
Feature | Analytics Software | Dave Fornell

Analytics in the past couple years have moved far beyond the simple dashboards used by many cardiology department ...

Home January 30, 2017
Home
Subscribe Now